Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Holland

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Sports Medicine and Physical Fitness|January 15, 2020
The metabolic demand of external load carriage in golfers: a comparison of a single versus double-strap golf bagChristopher J Holland, Mark S Godwin
Frontiers in Immunology|July 13, 2013
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not EnoughChristopher J Holland, David K Cole, Andrew Godkin
The Journal of Social Psychology|October 13, 2022
Communicating beyond the information given can make the communicator's attitudes toward a social group more extremeKaleigh A Decker, Charles G Lord, Christopher J Holland
Orthopaedic Journal of Sports Medicine|July 3, 2020
Acute Effects of Increased Joint Mobilization Treatment Duration on Ankle Function and Dynamic Postural Control in Female Athletes With Chronic Ankle InstabilityChristopher J Holland, Jonathan D Hughes, Mark B A De Ste Croix
Journal of Immunological Methods|June 19, 2012
TCR/pMHC Optimized Protein crystallization ScreenAnna M Bulek, Florian Madura, Anna Fuller, et al.
European Journal of Immunology|December 5, 2014
Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptidesFlorian Madura, Pierre J Rizkallah, Christopher J Holland, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individualsPaul L Ryan, Nital Sumaria, Christopher J Holland, et al.
Scientific Reports|September 7, 2012
Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimersChristopher J Holland, Pierre J Rizkallah, Sabrina Vollers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2015
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II MultimersChristopher J Holland, Garry Dolton, Martin Scurr, et al.
Immunotherapy Advances|July 1, 2025
Tumor cell spheroid-induced suppression of primary human cytotoxic T cells as a scalable <i>in vitro</i> model of exhaustionAmal Alsubaiti, Hanin Alamir, Lan Huynh, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Sports Medicine and Physical Fitness|January 15, 2020
The metabolic demand of external load carriage in golfers: a comparison of a single versus double-strap golf bagChristopher J Holland, Mark S Godwin
Frontiers in Immunology|July 13, 2013
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not EnoughChristopher J Holland, David K Cole, Andrew Godkin
The Journal of Social Psychology|October 13, 2022
Communicating beyond the information given can make the communicator's attitudes toward a social group more extremeKaleigh A Decker, Charles G Lord, Christopher J Holland
Orthopaedic Journal of Sports Medicine|July 3, 2020
Acute Effects of Increased Joint Mobilization Treatment Duration on Ankle Function and Dynamic Postural Control in Female Athletes With Chronic Ankle InstabilityChristopher J Holland, Jonathan D Hughes, Mark B A De Ste Croix
Journal of Immunological Methods|June 19, 2012
TCR/pMHC Optimized Protein crystallization ScreenAnna M Bulek, Florian Madura, Anna Fuller, et al.
European Journal of Immunology|December 5, 2014
Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptidesFlorian Madura, Pierre J Rizkallah, Christopher J Holland, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individualsPaul L Ryan, Nital Sumaria, Christopher J Holland, et al.
Scientific Reports|September 7, 2012
Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimersChristopher J Holland, Pierre J Rizkallah, Sabrina Vollers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2015
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II MultimersChristopher J Holland, Garry Dolton, Martin Scurr, et al.
Immunotherapy Advances|July 1, 2025
Tumor cell spheroid-induced suppression of primary human cytotoxic T cells as a scalable <i>in vitro</i> model of exhaustionAmal Alsubaiti, Hanin Alamir, Lan Huynh, et al.
Pageof 3